Xinyue Ning

机构：Shenyang Pharmaceutical University, General Hospital of Shenyang Military Region, Command Hospital, Northeastern University

发表论文 12 篇 · 总被引 52 次 · h-index 4

代表论文

• RETRACTED: Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer’s Disease (2022 · ACS Omega · 被引 19)
• Soluble TGF ‐β decoy receptor TGFBR3 exacerbates Alzheimer's disease pathology by modifying microglial function (2024 · Glia · 被引 15)
• Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3 (2024 · European Journal of Medicinal Chemistry · 被引 6)
• Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3β inhibitors with effective In vivo anti-AD activity (2025 · European Journal of Medicinal Chemistry · 被引 5)
• Fluorocyclopropyl-ContainingTacrine Derivatives asPotent and Selective Dual CDK2/CDK9 Inhibitors for the Treatment ofColorectal Cancer (2025 · Journal of Medicinal Chemistry · 被引 4)
• Multi-Target Inhibitor of ZJQ- 3 F Against AChE/BACE1/GSK3β Targets Improves the Cognitive Impairment of APP/PS1/Tau Triple-Transgenic Mouse Models of Alzheimer’s Disease (2025 · Molecular Neurobiology · 被引 2)